Shell Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-15,650
Closed -$1.25M 1125
2016
Q4
$1.25M Sell
15,650
-4,854
-24% -$385K 0.03% 555
2016
Q3
$1.64M Sell
20,504
-2,115
-9% -$171K 0.03% 478
2016
Q2
$1.76M Buy
22,619
+8,064
+55% +$575K 0.04% 420
2016
Q1
$801K Buy
14,555
+125
+0.9% +$6.81K 0.02% 586
2015
Q4
$891K Sell
14,430
-29,646
-67% -$1.87M 0.02% 579
2015
Q3
$2.65M Buy
44,076
+20,975
+91% +$1.5M 0.04% 366
2015
Q2
$1.69M Sell
23,101
-3,361
-13% -$243K 0.03% 479
2015
Q1
$1.73M Sell
26,462
-11,871
-31% -$789K 0.03% 489
2014
Q4
$2.49M Sell
38,333
-5,743
-13% -$370K 0.04% 400
2014
Q3
$2.65M Sell
44,076
-11
-0% -$719 0.04% 379
2014
Q2
$3.05M Sell
44,087
-3,844
-8% -$249K 0.05% 342
2014
Q1
$3.13M Buy
47,931
+332
+0.7% +$21.6K 0.05% 329
2013
Q4
$2.95M Sell
47,599
-20,372
-30% -$1.18M 0.05% 353
2013
Q3
$3.65M Sell
67,971
-3,233
-5% -$167K 0.07% 302
2013
Q2
$3.25M Buy
+71,204
New +$3.09M 0.06% 312

Other funds holding STJ

Shell Asset Management's STJ Position: Q1 2017 in Review

Shell Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 15,650 shares — an estimated $1.25M sold.

Shell Asset Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $3.65M in Q3 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Shell Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Shell Asset Management sold 15,650 St Jude Medical shares in Q1 2017, an estimated $1.25M.
  • Shell Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Shell Asset Management's St Jude Medical position peaked at $3.65M in Q3 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Shell Asset Management's 13F filing for Q1 2017, filed 26 Apr 2017.